Effects of vildagliptin as add-on treatment in patients with type 2 diabetes mellitus: insights from long-term clinical studies in Japan
Crossref DOI link: https://doi.org/10.1186/s40200-016-0240-z
Published Online: 2016-07-04
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Odawara, Masato
Sagara, Rieko
Funding for this research was provided by:
Novartis Pharm K.K.
Text and Data Mining valid from 2015-12-01
Version of Record valid from 2016-07-04
Article History
Received: 3 March 2016
Accepted: 12 June 2016
First Online: 4 July 2016